SPAAR

The SPAAR/SPAR locus (LINC00961) encodes a polypeptide with two functionally distinct, tissue-specific activities (PMID:28024296, PMID:11502259). In non-neuronal tissues, the SPAAR micropeptide localizes to the late endosome/lysosome and binds the lysosomal v-ATPase to selectively suppress amino acid-stimulated mTORC1 activation, and its downregulation upon skeletal muscle injury licenses mTORC1 signaling to promote muscle regeneration (PMID:28024296); in endothelial cells SPAAR binds the actin-associated protein SYNE1 and supports tubule formation and capillary density in ischemic muscle (PMID:31990292). In neurons, SPAR functions as a Rap-specific GTPase-activating protein that binds the guanylate kinase-like domain of PSD-95, forms a complex with NMDA receptors, reorganizes the actin cytoskeleton, and enlarges dendritic spine heads (PMID:11502259). SPAR acts downstream of the EphA4 receptor, whose C-terminus engages the SPAR PDZ domain to drive Rap1 inactivation required for ephrin-A-dependent growth cone collapse (PMID:18094260), and is integrated into the postsynaptic scaffold and actin machinery through ProSAPiP1/Shank3, PDLIM5, and alpha-actinin2 (PMID:16522626, PMID:19900557, PMID:19393616). SPAR abundance is tightly controlled by activity-dependent proteasomal degradation: Plk2/SNK phosphorylates a phosphodegron that recruits the SCF(β-TrCP) E3 ligase, and LTP induction triggers UPS-dependent SPAR turnover via CDK5- and NMDA receptor-dependent routes (PMID:18723513, PMID:21987493).

1. 2001 High

   Established SPAR as a postsynaptic Rap-GAP that physically couples to the PSD-95/NMDA receptor scaffold and shapes dendritic spine morphology, defining its core synaptic function.

   Evidence Co-IP from brain lysate, heterologous actin readout, and hippocampal neuron gain/loss-of-function with domain deletions

   PMID:11502259

   Open questions at the time

   • Endogenous loss-of-function phenotype not established
   • Downstream Rap effectors driving spine enlargement not resolved
2. 2006 Medium

   Identified how SPAR is physically recruited to synapses, linking it to the ProSAP/Shank scaffold via ProSAPiP1.

   Evidence Co-IP, yeast two-hybrid, and co-localization in hippocampal neurons

   PMID:16522626

   Open questions at the time

   • Single lab
   • Functional consequence of recruitment for spine signaling not tested here
3. 2007 High

   Placed SPAR in a receptor-driven signaling axis by showing EphA4 engages its PDZ domain to inactivate Rap1 for growth cone collapse and adhesion control.

   Evidence Co-IP of EphA4 with SPAR, dominant-negative/constitutively active Rap constructs, growth cone collapse and integrin adhesion assays

   PMID:18094260

   Open questions at the time

   • Spatial dynamics of EphA4-SPAR recruitment not resolved
   • Rap2-independence of collapse mechanism not fully explained
4. 2008 High

   Defined the degradation mechanism controlling SPAR levels: activity-induced Plk2 phosphorylation creates a phosphodegron recognized by SCF(β-TrCP).

   Evidence Co-IP of SPAR with SCF components, phosphodegron mapping, dominant-negative β-TrCP/Cul1 rescue in neurons

   PMID:18723513

   Open questions at the time

   • Precise phosphodegron residues and Plk2 kinetics in vivo
   • Link to spine remodeling outcome not directly demonstrated
5. 2009 Medium

   Expanded the SPAR interactome to actin/scaffold partners that counterbalance its spine-enlarging activity, revealing combinatorial control of spine morphology.

   Evidence Co-IP, RNAi/overexpression of PDLIM5 and alpha-actinin2 in hippocampal neurons with morphological readouts and PKC pharmacology

   PMID:19393616 PMID:19900557

   Open questions at the time

   • Single-lab interactions
   • Direct vs indirect binding to actin machinery not fully dissected
6. 2011 Medium

   Connected SPAR turnover to synaptic plasticity by showing LTP triggers UPS-dependent SPAR degradation through parallel CDK5- and NMDA receptor-dependent routes.

   Evidence Live imaging of eGFP-SPAR in acute hippocampal slices with LTP induction and pharmacological inhibition of CDK5, proteasome, and protein synthesis

   PMID:21987493

   Open questions at the time

   • Relationship between CDK5 and Plk2/β-TrCP routes unresolved
   • Single lab
7. 2016 High

   Revealed a second, non-neuronal function of the same locus: the SPAAR micropeptide restrains amino acid-specific mTORC1 activation via the lysosomal v-ATPase to gate muscle regeneration.

   Evidence Subcellular fractionation, reciprocal Co-IP with v-ATPase, SPAR-specific CRISPR KO mouse, in vivo muscle injury model

   PMID:28024296

   Open questions at the time

   • Molecular basis for amino-acid versus growth-factor selectivity unclear
   • How v-ATPase binding mechanistically blocks mTORC1 not resolved
8. 2020 Medium

   Extended SPAAR function to angiogenesis, identifying SYNE1 as a binding partner and an in vivo role in capillary formation after ischemia.

   Evidence ORF overexpression and tubule assays in primary endothelial cells, pull-down/MS, LINC00961 KO mouse hindlimb ischemia

   PMID:31990292

   Open questions at the time

   • Functional significance of SYNE1 binding not mechanistically defined
   • Relationship to the v-ATPase/mTORC1 axis in endothelium unknown
9. 2021 Low

   Provided evolutionary context, showing SPAAR's protein structure is conserved across mammals with independent primate-specific isoform origination.

   Evidence Comparative genomics, syntenic alignment, and evolutionary rate analysis

   PMID:34946813

   Open questions at the time

   • Computational only, no biochemical test
   • Functional consequence of primate isoforms unknown

• How a single short ORF executes two unrelated molecular functions — lysosomal mTORC1 suppression versus postsynaptic Rap-GAP/scaffold activity — and whether these reflect distinct isoforms, cell-type-specific partners, or shared structural elements remains unresolved.
• No structural model reconciling the two activities
• Cross-tissue comparison of the same protein product lacking
• GAP catalytic versus micropeptide functions not tested in the same system